A Prospective Pilot Study of Pencil Beam Scanning Proton Radiation Therapy as a Component of Trimodality Therapy for Esophageal Cancer
Christopher L. Hallemeier(Mayo Clinic in Arizona), Michael G. Haddock(Mayo Clinic in Arizona), Bret D. Kazemba(Mayo Clinic), William S. Harmsen(Mayo Clinic), Harry H. Yoon(Mayo Clinic), Jason K. Viehman(Mayo Clinic), E. Tryggestad(Mayo Clinic), Shanda H. Blackmon(The University of Texas MD Anderson Cancer Center), M.A. Neben-Wittich(Mayo Clinic), Krishan R. Jethwa(Mayo Clinic), Kenneth W. Merrell(Mayo Clinic), K. Robert Shen, Henry C. Pitot(Mayo Clinic), Broc Giffey(Mayo Clinic)
Cited by 3
Related Papers
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
|JAMA Oncology|2018|1.8k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
|Circulation|1993|608